Effects of motilitone on the improvement of dyspeptic symptoms in patients with depression and anxiety disorder comorbid with dyspepsia: double-blind, randomized, placebo controlled trial

Wonkwang University Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新: 2020年5月18日

适应症

试验速览

暂无简介。

•19 to 70 years old.
•- Patients diagnosed with depression or anxiety disorder by a psychiatrist (DSM5 diagnosis criteria)
•- Patients diagnosed with functional indigestion by a gastrointestinal surgeon (Rome IV createria)

•- Patients whose substrate gastrointestinal diseases have been identified through gastroscopy
•- A person who has undergone surgery that can affect gastrointestinal motion or a patient with a history of gastrointestinal surgery
•- Patients who do not understand the purpose of this study
•- Patients who have participated in a gastrointestinal drug clinical trial within the last three months
•- Pregnant women, breastfeeding women and women in childbearing age who do not use proper contraception methods
•- use of benzodiazepines, sleeping fill, etc. is permitted under conditions of constant capacity during clinical trials.
•- Serious active medical conditions that may affect the quality of life scale are excluded. These include thyroid and adrenal cortical holmon diseases, consumptive or infectious diseases, active cancer diseases, chronic rheumatoid and autoimmune diseases, hepatitis and liver cirrhosis, acute heart failure or myocardial infarction, and acute respiratory diseases.

发起方